| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004153 Novel heteroaryl-diazabicycloalkanes |
| 01/02/2003 | US20030004152 Method of treating sexual disturbances |
| 01/02/2003 | US20030004150 New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them |
| 01/02/2003 | US20030000518 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 01/02/2003 | EP1270576A2 3-phenyl-3,7-diazabicyclo[3,3,1]nonanes, process for their preparation and pharmaceutical compositions containing them |
| 01/02/2003 | EP1270572A1 Condensed pyrazole derivatives, process for producing the same and use thereof |
| 01/02/2003 | EP1270570A1 Amide compounds and use thereof |
| 01/02/2003 | EP1268481A2 Kinase inhibitors as therapeutic agents |
| 01/02/2003 | EP1268479A1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands |
| 01/02/2003 | EP1268478A2 Phenyl-substituted imidazopyridines |
| 01/02/2003 | EP1268477A1 Substituted beta-carbolines with ikb-kinase inhibiting activity |
| 01/02/2003 | EP1268476A1 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors |
| 01/02/2003 | EP1268470A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 01/02/2003 | EP1268466A1 Decahydro-isoquinolines |
| 01/02/2003 | EP1268444A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/02/2003 | EP1268443A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 01/02/2003 | EP1268431A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 01/02/2003 | EP1268429A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/02/2003 | EP1268421A2 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 01/02/2003 | EP1268408A1 Arthropodicidal carboxanilides |
| 01/02/2003 | EP1268000A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 01/02/2003 | EP1267877A1 Use of pyrido 3,2-e]-pyrazinones as inhibitors of phosphodiesterase 5 for treating erectile dysfunction |
| 01/02/2003 | EP1267876A1 Thrombin inhibitors |
| 01/02/2003 | EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 01/02/2003 | EP1053246B1 Beta-sheet mimetics and methods relating to the use thereof |
| 01/01/2003 | CN1388804A Amino acid-N-carboxy anhydrides having substitent at nitrogen |
| 12/31/2002 | WO2002002117A1 Therapeutic or preventive medicines for mood disorders or anxiety disorders |
| 12/31/2002 | US6500953 Preparation of camptothecin and nothapodytine derivatives |
| 12/31/2002 | US6500855 Nitrogen containing aromatic heterocycles with ortho-substituted p1 groups; anticoagulants |
| 12/31/2002 | US6500839 CRF receptor antagonists and methods relating thereto |
| 12/31/2002 | US6500837 Treating parkinson's disease |
| 12/31/2002 | CA2414971A1 Drug for curing or preventing mood disorder or anxiety disorder |
| 12/27/2002 | WO2002102976A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 12/27/2002 | WO2002102793A2 Quinazolinediones as antibacterial agents |
| 12/27/2002 | WO2002102792A1 Novel heterocyclic antibacterial compounds |
| 12/27/2002 | WO2002102783A1 Tyrosine kinase inhibitors |
| 12/27/2002 | WO2002102377A1 Immune response modifiers for the treatment of periodontal disease |
| 12/27/2002 | WO2002102374A1 Amine salt of an integrin receptor antagonist |
| 12/27/2002 | WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 12/27/2002 | WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | WO2002076946A3 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain. |
| 12/27/2002 | WO2002074753A3 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 12/27/2002 | WO2002009758A3 Inhibitors of cellular efflux pumps of microbes |
| 12/27/2002 | WO2002009702A3 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 12/27/2002 | WO2001085095B1 Chiral fluoroquinolizinone arginine salt forms |
| 12/27/2002 | WO2001052855A8 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 12/27/2002 | CA2753372A1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 12/27/2002 | CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2449754A1 Immune response modifiers for the treatment of periodontal disease |
| 12/27/2002 | CA2446963A1 Quinazolinediones as antibacterial agents |
| 12/26/2002 | US20020198423 Convenient and efficient suzuki-miyaura cross-coupling catalyzed by a palladium/diazabutadiene system |
| 12/26/2002 | US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions |
| 12/26/2002 | US20020198213 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 12/26/2002 | US20020198207 Novel Hexanoic acid derivatives |
| 12/26/2002 | US20020198204 Certain fused pyrrolecarboxamides; a new class of GABA brain receptor |
| 12/26/2002 | US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa |
| 12/26/2002 | US20020198191 Cyclohexylphenyl vasopressin agonists |
| 12/26/2002 | US20020198190 Tetracyclic 1,2,3,4,5,6- hexahydroazepino-(4,5-b)indole derivatives having a ring connecting position 6 (N-6) and position 7 (C-7); treating or preventing a disease or disorder of the central nervous system in a mammal |
| 12/26/2002 | US20020198187 Method of treating sexual disturbances |
| 12/26/2002 | US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 12/26/2002 | US20020197561 Information layer comprises a light-absorbent compound that is a dye which cyclizes thermally |
| 12/25/2002 | CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors |
| 12/25/2002 | CN1387526A Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof |
| 12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 12/25/2002 | CN1097056C Counterpart of camptothecin, their application as medicine and pharmaceutical compositions contg. them |
| 12/25/2002 | CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides |
| 12/24/2002 | US6498251 Tetrahydrobenzindole derivatives |
| 12/24/2002 | US6498176 Inhibiting tumor growth via inhibition of tumor-related angiogenesis |
| 12/24/2002 | US6498167 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 12/24/2002 | US6498166 Pyrazolopyridines |
| 12/24/2002 | US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis |
| 12/24/2002 | US6498163 Pyrido[2,3-D]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation |
| 12/24/2002 | US6498159 Such as 4-((3-chloro-4-methoxybenzyl)amino)-1-((4-hydroxy-4 -hydroxymethyl)piperidino)-6-phthalazine carbonitrile |
| 12/24/2002 | CA2214744C 3-(bis-substituted phenylmethylene)oxindole derivatives |
| 12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |
| 12/24/2002 | CA2131019C Nitrosation process |
| 12/24/2002 | CA2038984C Hydroxymethyl-indolizidines and quinolizidines |
| 12/19/2002 | WO2002100977A1 Organic electroluminescence device and luminance material |
| 12/19/2002 | WO2002100888A1 Somatostatin-dopamine chimeric analogs |
| 12/19/2002 | WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 12/19/2002 | WO2002100863A1 Corticotropin releasing factor antagonists |
| 12/19/2002 | WO2002100862A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 12/19/2002 | WO2002100861A1 1-(3-phenyloxypropyl)piperidine derivatives |
| 12/19/2002 | WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 12/19/2002 | WO2002100859A1 Pde iv inhibitors |
| 12/19/2002 | WO2002100857A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 12/19/2002 | WO2002100851A2 Thiophene derivatives as antiviral agents for flavivirus infection |
| 12/19/2002 | WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 12/19/2002 | WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 12/19/2002 | WO2002100826A2 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs |
| 12/19/2002 | WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/19/2002 | WO2002100350A2 Dopamine receptor ligands and therapeutic methods based thereon |
| 12/19/2002 | WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors |
| 12/19/2002 | WO2002076396A3 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases |
| 12/19/2002 | WO2002070541A3 Peptide deformylase inhibitors |